« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 15, Issue 8
, Pages 971-981
, August 2009
HLA-A Disparities Illustrate Challenges for Ranking the Impact of HLA Mismatches on Bone Marrow Transplant Outcomes in the United States
References
- High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110:4576–4583
- National Marrow Donor Program HLA-matching guidelines for unrelated marrow transplants. Biol Blood Marrow Transplant. 2003;9:610–615
- National marrow donor program HLA matching guidelines for unrelated adult donor hematopoietic cell transplants. Biol Blood Marrow Transplant. 2008;14(Suppl):45–53
- Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood. 2004;104:1923–1930
- The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002;99:4200–4206
- HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival. Biol Blood Marrow Transplant. 2007;13:965–974
- Limits of HLA mismatching in unrelated hematopoietic cell transplantation. Blood. 2004;104:2976–2980
- Major-histocompatibility-complex class I alleles and antigens in hematopoietic-cell transplantation. N Engl J Med. 2001;345:1794–1800
- Definition of HLA-DQ as a transplantation antigen. Proc Natl Acad Sci USA. 1996;93:15358–15363
- The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation. Blood. 2007;110:4560–4566
- Hla-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease. Transplantation. 2004;77:1107–1110
- High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood. 2007;110:2235–2241
- . Lies, damn lies, and statistics: the perils of the P value. Am J Transplant. 2006;6:10–11
- Effect of HLA-A2 allele disparity on clinical outcome in hematopoietic cell transplantation from unrelated donors. Tissue Antigens/. 2007;69(Suppl 1):31–35
- T cell allorecognition and MHC restriction—a case of Jekyll and Hyde?. Mol Immunol. 2008;45:583–598
- . Specificity of T-cell alloreactivity. Nat Rev Immunol. 2007;7:942–953
- HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool. Bone Marrow Transplant. 2004;33:165–169
- The HistoCheck algorithm does not predict T-cell alloreactivity in vitro. Bone Marrow Transplant. 2005;36:927–928
- Scoring for HLA matching? A clinical test of HistoCheck. Bone Marrow Transplant. 2004;34:367–368author reply 369
- HLAMatchmaker-defined triplet matching is not associated with better survival rates of patients with class I HLA allele mismatched hematopoietic cell transplants from unrelated donors. Biol Blood Marrow Transplant. 2008;14:1064–1071
- A high degree of HLA disparity arises from limited allelic diversity: analysis of 1775 unrelated bone marrow transplant donor-recipient pairs. Hum Immunol. 2007;68:30–40
- IMGT/HLA Database—a sequence database for the human major histocompatibility complex. Nucleic Acids Res. 2001;29:210–213
- Structure of the human class I histocompatibility antigen, HLA-A2. Nature. 1987;329:506–512
- . Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol. 1991;219:277–319
- Specificity pockets for the side chains of peptide antigens in HLA-Aw68. Nature. 1989;342:692–696
- . A roadmap for HLA-A, HLA-B, and HLA-C peptide binding specificities. Immunogenetics. 1996;45:15–26
- Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation. 1974;18:295–304
- Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med. 1980;69:204–217
- Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population. Biochemistry. 1995;34:10130–10138
- Human leukocyte antigen phenotype imposes complex constraints on the antigen-specific cytotoxic T lymphocyte repertoire. Eur J Immunol. 1997;27:178–182
- HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation. Bone Marrow Transplant. 1994;14:137–145
- Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44. N Engl J Med. 1990;323:1818–1822
- Imanishi T, et al. HLA 1991 Proceedings of the Eleventh Histocompatibility Workshop and Conference. In Eleventh Histocompatibility Workshop and Conference, 1991. Yokahama Japan: Oxford University Press.
- Allogeneic MHC class I molecules with numerous sequence differences do not elicit a CTL response. Hum Immunol. 2005;66:969–976
- . How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol. 2006;24:419–466
Financial disclosure: See Acknowledgments on page 980.
PII: S1083-8791(09)00216-X
doi: 10.1016/j.bbmt.2009.04.015
© 2009 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Biology of Blood and Marrow Transplantation
Volume 15, Issue 8
, Pages 971-981
, August 2009
